Method of determining the viability of tissue in an organism

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4824660
SERIAL NO

06741805

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of determining the viability of tissue in a region of an organism comprises the steps of introducing an ATP repleting agent into the region and monitoring the region to determine its effect on T1-201 distribution in the region. The capability of viable tissue to synthesize ATP and increase its ATP stores provides an indication of the viability of the tissue in the region. In a preferred embodiment of the method, ribose, which is a high energy phosphate precursor and an ATP repleting agent, is introduced into heart tissue that is being monitored by T1-201 scintigraphy. The ribose increases the rate and extent of T1-201 distribution in the heart tissue, thereby allowing the determination of viable 'stunned' heart tissue. That viable tissue is distinguishable from nonviable tissue is attributed to the capability of the former to synthesize ATP and increase its ATP stores in response to the administration of the ATP repleting agent. Such manipulation of ATP stores in a region of tissue effects a detectable change in T1-201 distribution in that region. The method permits, therefore, the rapid determination of viable heart tissue.R

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
ANGELLO; PAUL S.LAKE OSWEGO, OR0
ANGELLO, PAUL S., 1858 PALISADES TERRACE DRIVE, LAKE OSWEGO, OREGON 97034LAKE OSWEGO, OR0

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Angello, Debra A Charlottesville, VA 1 34
Wilson, Richard A Lake Oswego, OR 100 1302

Cited Art Landscape

Patent Info (Count) # Cites Year
 
UNIVERSITY OF VIRGINIA (1)
* 4364922 Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances 28 1980
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (1)
* 2009/0197,818 Use Of Ribose for Recovery From Anaesthesia 2 2005
 
SIEMENS MEDICAL SOLUTIONS USA, INC. (1)
* 6015384 Ultrasonic system and method for tissue viability imaging 20 1998
 
UNIVERSITY OF VIRGINIA (30)
* 6117878 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors 60 1998
6322771 Induction of pharmacological stress with adenosine receptor agonists 46 1999
6448235 Method for treating restenosis with A2A adenosine receptor agonists 41 2000
6514949 Method compositions for treating the inflammatory response 41 2000
6531457 Methods and compositions for treating inflammatory response 32 2001
6670334 Method and compositions for treating the inflammatory response 32 2002
7214665 2-propynyl adenosine analogs having A.sub.2A agonist activity and compositions thereof 18 2002
7226913 Pharmaceutical compositions having A.sub.2A adenosine receptor agonist activity 10 2003
7427606 Method to reduce inflammatory response in transplanted tissue 11 2004
* 2005/0182,018 Method to reduce inflammatory response in transplanted tissue 2 2004
7605143 agonist activity 10 2005
7576069 2-polycyclic propynyl adenosine analogs having A2A agonist activity 13 2005
7442687 2-polycyclic propynyl adenosine analogs having A2A agonist activity 7 2005
* 2006/0217,343 2-Polycyclic propynyl adenosine analogs having A2A agonist activity 1 2005
* 2006/0040,889 2-polycyclic propynyl adenosine analogs having A2A agonist activity 15 2005
* 2006/0040,888 2-propynyl adenosine analogs with modifed 5'-ribose groups having A2A agonist activity 12 2005
7378400 Method to reduce an inflammatory response from arthritis 14 2005
* 2006/0100,169 Method to reduce an inflammatory response from arthritis 1 2005
8178509 Method to treat sickle cell disease 0 2007
7737127 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof 5 2007
* 2007/0232,559 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF 9 2007
* 2007/0265,440 METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY RESPONSE 6 2007
8188063 modulators to treat spinal cord injury 2 2007
* 2008/0064,653 USE OF ADENOSINE A2A MODULATORS TO TREAT SPINAL CORD INJURY 12 2007
* 2009/0162,282 SUBSTITUTED 4--PIPERIDINE-1-CARBOXYLIC ACID ESTERS AS A2AR AGONISTS 6 2008
7989431 2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity 3 2009
7875595 2-polycyclic propynyl adenosine analogs having A2A agonist activity 4 2009
8158604 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof 0 2010
* 2010/0152,127 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF 4 2010
* 2011/0136,755 2-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY 3 2011
 
ADERIS PHARMACEUTICALS, INC. (3)
* 5117830 Method of determining viability of tissue 33 1990
* 5256398 Composition for determining viability of tissue 10 1992
* 5477857 Diagnostic uses of hydrazinoadenosines 10 1993
 
VARIAN MEDICAL SYSTEMS, INC. (2)
* 8660335 Transient pixel defect detection and correction 0 2010
* 2011/0235,940 TRANSIENT PIXEL DEFECT DETECTION AND CORRECTION 1 2010
 
RIBOCOR, INC. (1)
9572882 Compositions and methods for improving cardiovascular function 0 2009
 
BIOENERGY LIFE SCIENCE, INC. (2)
* 6159942 Compositions for increasing energy in vivo 24 1999
6534480 Compositions for increasing energy in vivo 8 2000
 
PATENT FOUNDATION, VIRGINIA, UNIVERSITY OF (1)
6232297 Methods and compositions for treating inflammatory response 29 1999
 
BIOENERGY, INC. (10)
6339716 Method for determining viability of a myocardial segment 8 1999
6218366 Method for raising the hypoxic threshold 13 1999
* 6159943 Use of ribose to prevent cramping and soreness in muscles 9 1999
6703370 Use of ribose to treat fibromyalgia 2 2000
* 2005/0277,598 Method for improving ventilatory efficiency 2 2005
* 2010/0099,630 Method for improving ventilatory efficiency 1 2006
8101581 Use of D-ribose to treat cardiac arrhythmias 6 2008
* 2008/0176,809 Use of D-ribose to treat cardiac arrhythmias 1 2008
* 2010/0055,206 Use of ribose in first response to acute myocardial infarction 1 2009
* 2010/0009,924 Compositions and methods for improving cardiovascular function 2 2009
 
University of Virginia Patent Foundation and Adenosine Therapeutics, L.L.C. (1)
* 2009/0253,647 2-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY 6 2009
 
PGXHEALTH, LLC (1)
8058259 R agonists 4 2008
* Cited By Examiner